Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro

  • Authors:
    • Ladislava Schröterová
    • Alena Ježková
    • Emil Rudolf
    • Kateřina Caltová
    • Věra Králová
    • Veronika Hanušová
  • View Affiliations

  • Published online on: July 19, 2018     https://doi.org/10.3892/ijo.2018.4488
  • Pages: 1625-1632
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Inositol hexaphosphate (IP6), also known as phytic acid, has been shown to exhibit anticancer effects in a number of preclinical tumor models. IP6 decreases proliferation by arresting cells in the G0/G1 phase, inhibits iron-mediated oxidative reactions, enhances differentiation and stimulates apoptosis. The present study attempted to characterize the effect of IP6 on the migration and adhesion of colon cancer SW620 cells. IP6 was assessed at concentrations of 0.2 and 1 mM during 12, 24 and 48 h of exposure. Migration ability was measured with the real-time xCELLigence Real-Time Cell Analyzer Dual Purpose system. The expression of mRNA and proteins involved in migration and cancer progression [epithelial cell adhesion molecule, intercellular adhesion molecule-1, β-catenin, N-cadherin, E-cadherin, matrix metalloproteinase (MMP)-2 and MMP-9] was determined by reverse transcription-quantitative polymerase chain reaction and western blot analysis. The changes in the expression and subcellular localization of E-cadherin were determined by indirect immunofluorescence. IP6 induced a decrease in the migration ability of the tested SW620 cell line. IP6-treated cells also showed decreased expression of N-cadherin, increased levels of E-cadherin and decreased expression of MMP-2 and MMP-9. These results indicated that IP6 has potential to modulate the migration ability and expression of markers associated with invasion in SW620 cells; however, further analysis is necessary to obtain a detailed understanding of the mechanism of action.

References

1 

McGuire S: World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press; 2015

Adv Nutr. 7:418–419. 2016. View Article : Google Scholar

2 

Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global patterns and trends in colorectal cancer incidence and mortality. Gut. 66:683–691. 2017. View Article : Google Scholar

3 

Liu G, Song Y, Cui L, Wen Z and Lu X: Inositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential target. Int J Clin Exp Pathol. 8:1402–1410. 2015.PubMed/NCBI

4 

Vucenik I, Ramakrishna G, Tantivejkul K, Anderson LM and Ramljak D: Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Res Treat. 91:35–45. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I and Shamsuddin AM: IP6 in treatment of liver cancer. I IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res. 18:4083–4090. 1998.

6 

Gu M, Roy S, Raina K, Agarwal C and Agarwal R: Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target. Cancer Res. 69:9465–9472. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Wawszczyk J, Kapral M, Lodowska J, Jesse K, Hollek A and Węglarz L: Antiproliferative effect of inositol hexaphosphate on human skin melanoma cells in vitro. Acta Pol Pharm. 72:895–900. 2015.PubMed/NCBI

8 

Wei J, Cheang T, Tang B, Xia H, Xing Z, Chen Z, Fang Y, Chen W, Xu A, Wang S, et al: The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA. Biomaterials. 34:1246–1254. 2013. View Article : Google Scholar

9 

El-Sherbiny YM, Cox MC, Ismail ZA, Shamsuddin AM and Vucenik I: G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res. 21:2393–2403. 2001.PubMed/NCBI

10 

Owen RW, Weisgerber UM, Spiegelhalder B and Bartsch H: Faecal phytic acid and its relation to other putative markers of risk for colorectal cancer. Gut. 38:591–597. 1996. View Article : Google Scholar : PubMed/NCBI

11 

Bozsik A, Kökény S and Olah E: Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6). Cancer Genomics Proteomics. 4:43–51. 2007.PubMed/NCBI

12 

Cholewa K, Parfiniewicz B, Bednarek I, Swiatkowska L, Jezienicka E, Kierot J and Weglarz L: The influence of phytic acid on TNF-alpha and its receptors genes' expression in colon cancer Caco-2 cells. Acta Pol Pharm. 65:75–79. 2008.PubMed/NCBI

13 

Sakamoto K, Venkatraman G and Shamsuddin AM: Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis. 14:1815–1819. 1993. View Article : Google Scholar : PubMed/NCBI

14 

Fu M, Song Y, Wen Z, Lu X and Cui L: Inositol hexaphosphate and inositol inhibit colorectal cancer metastasis to the liver in BALB/c mice. Nutrients. 8:82016. View Article : Google Scholar

15 

Kapral M, Wawszczyk J, Jurzak M, Hollek A and Węglarz L: The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells. Int J Colorectal Dis. 27:1419–1428. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Tantivejkul K, Vucenik I and Shamsuddin AM: Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB231 human breast cancer cells. Anticancer Res. 23:3671–3679. 2003.PubMed/NCBI

17 

Tantivejkul K, Vucenik I and Shamsuddin AM: Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions. Anticancer Res. 23:3681–3689. 2003.PubMed/NCBI

18 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

19 

Schroterova L, Haskova P, Rudolf E and Cervinka M: Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma. Oncol Rep. 23:787–793. 2010.PubMed/NCBI

20 

Shamsuddin AM, Vucenik I and Cole KE: IP6: A novel anticancer agent. Life Sci. 61:343–354. 1997. View Article : Google Scholar

21 

McFadden DW, Riggs DR, Jackson BJ and Cunningham C: Corn-derived carbohydrate inositol hexaphosphate inhibits Barrett's adenocarcinoma growth by pro-apoptotic mechanisms. Oncol Rep. 19:563–566. 2008.PubMed/NCBI

22 

Sharma G, Singh RP and Agarwal R: Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells. Int J Oncol. 23:1413–1418. 2003.PubMed/NCBI

23 

Somasundar P, Riggs DR, Jackson BJ, Cunningham C, Vona-Davis L and McFadden DW: Inositol hexaphosphate (IP6): A novel treatment for pancreatic cancer. J Surg Res. 126:199–203. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Vucenik I, Kalebic T, Tantivejkul K and Shamsuddin AM: Novel anticancer function of inositol hexaphosphate: Inhibition of human rhabdomyosarcoma in vitro and in vivo. Anticancer Res. 18:1377–1384. 1998.PubMed/NCBI

25 

Vucenik I, Tomazic VJ, Fabian D and Shamsuddin AM: Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study. Cancer Lett. 65:9–13. 1992. View Article : Google Scholar : PubMed/NCBI

26 

Oloumi A, McPhee T and Dedhar S: Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta. 1691:1–15. 2004. View Article : Google Scholar : PubMed/NCBI

27 

Stockinger A, Eger A, Wolf J, Beug H and Foisner R: E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol. 154:1185–1196. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Saad N, Esa NM and Ithnin H: Suppression of β-catenin and cyclooxygenase-2 expression and cell proliferation in azoxymethane-induced colonic cancer in rats by rice bran phytic acid (PA). Asian Pac J Cancer Prev. 14:3093–3099. 2013. View Article : Google Scholar

29 

Todosi AM, Gavrilescu MM, Aniţei GM, Filip B and Scripcariu V: Colon cancer at the molecular level - usefulness of epithelial-mesenchymal transition analysis. Rev Med Chir Soc Med Nat Iasi. 116:1106–1111. 2012.

30 

Dai M, Yuan F, Fu C and Shen G, Hu S and Shen G: Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis. PLoS One. 12:e01753572017. View Article : Google Scholar : PubMed/NCBI

31 

Yang Y, Jun CD, Liu JH, Zhang R, Joachimiak A, Springer TA and Wang JH: Structural basis for dimerization of ICAM-1 on the cell surface. Mol Cell. 14:269–276. 2004. View Article : Google Scholar : PubMed/NCBI

32 

Paschos KA, Canovas D and Bird NC: The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal. 21:665–674. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Kapral M, Wawszczyk J, Jurzak M, Dymitruk D and Weglarz L: Evaluation of the expression of metalloproteinases 2 and 9 and their tissue inhibitors in colon cancer cells treated with phytic acid. Acta Pol Pharm. 67:625–629. 2010.

Related Articles

Journal Cover

October 2018
Volume 53 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Schröterová, L., Ježková, A., Rudolf, E., Caltová, K., Králová, V., & Hanušová, V. (2018). Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro. International Journal of Oncology, 53, 1625-1632. https://doi.org/10.3892/ijo.2018.4488
MLA
Schröterová, L., Ježková, A., Rudolf, E., Caltová, K., Králová, V., Hanušová, V."Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro". International Journal of Oncology 53.4 (2018): 1625-1632.
Chicago
Schröterová, L., Ježková, A., Rudolf, E., Caltová, K., Králová, V., Hanušová, V."Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro". International Journal of Oncology 53, no. 4 (2018): 1625-1632. https://doi.org/10.3892/ijo.2018.4488